Skip to main content
Top
Published in: International Journal of Behavioral Medicine 1/2023

07-03-2022 | Ulcerative Colitis | Full length manuscript

Illness Identity in Inflammatory Bowel Disease

Authors: Jessica Rassart, Carine Van Wanseele, Lynn Debrun, Koen Matthijs, Philip Moons, Liesbet Van Bulck, Seher Arat, Lukas Van Oudenhove, Koen Luyckx

Published in: International Journal of Behavioral Medicine | Issue 1/2023

Login to get access

Abstract

Background

We examined the degree to which adults with inflammatory bowel disease (IBD) integrated their illness into their identity and linked illness identity to important patient-reported outcomes.

Methods

A total of 109 adults with IBD, aged 18 to 60 (Mage = 35.93; 77% women) completed questionnaires on the four illness identity dimensions (rejection, acceptance, engulfment, and enrichment), medication adherence, depressive symptoms, life satisfaction, health status, and health-related quality of life (HRQoL). The illness identity scores of adults with IBD were compared to existing data from adults with congenital heart disease (CHD), refractory epilepsy (RE), and multisystemic connective tissue disorders (MSDs) using multivariate analyses of covariance. In adults with IBD, associations between illness identity and patient-reported outcomes were examined through hierarchical regression analyses, controlling for sex, age, illness duration, diagnosis, self-reported flares, and co-existing illnesses.

Results

Adults with IBD scored higher on rejection and engulfment and lower on acceptance than adults with CHD, lower on rejection but higher on engulfment than adults with RE, and higher on engulfment and enrichment but lower on rejection than adults with MSDs. Higher engulfment scores were related to more depressive symptoms, lower life satisfaction, and a poorer health status and HRQoL. In contrast, higher enrichment scores were related to more life satisfaction and a better HRQoL. Rejection and acceptance were not uniquely related to any of the outcomes.

Conclusions

Adults with IBD showed relatively high levels of engulfment. Substantial associations were observed between illness identity and patient-reported outcomes, with engulfment being the strongest, most consistent predictor.
Appendix
Available only for authorised users
Footnotes
1
Because of the small sample size, we had to limit the number of control variables. Regression analyses including marital status and education level as additional control variables resulted in identical findings.
 
Literature
1.
go back to reference Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analysis — part I. Inflamm Bowel Dis. 2018;24:742–50.CrossRef Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analysis — part I. Inflamm Bowel Dis. 2018;24:742–50.CrossRef
2.
go back to reference Neuendorf R, Harding A, Stello N, Hanes D, Wahbehab H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.CrossRef Neuendorf R, Harding A, Stello N, Hanes D, Wahbehab H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.CrossRef
3.
go back to reference Navabi S, Gorrepati VS, Yadav S, et al. Influences and impact of anxiety and depression in the setting of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:2303–8.CrossRef Navabi S, Gorrepati VS, Yadav S, et al. Influences and impact of anxiety and depression in the setting of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:2303–8.CrossRef
4.
go back to reference Shah NB, Haydek J, Slaughter J, et al. Risk factors for medication nonadherence to self-injectable biological therapy in adult patients with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:314–20.CrossRef Shah NB, Haydek J, Slaughter J, et al. Risk factors for medication nonadherence to self-injectable biological therapy in adult patients with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:314–20.CrossRef
5.
go back to reference Govani SM, Noureldin M, Higgins PDR, et al. Defining an optimal adherence threshold for patients taking subcutaneous anti-TNFs for inflammatory bowel diseases. Am J Gastroenterol. 2018;113:276–82.CrossRef Govani SM, Noureldin M, Higgins PDR, et al. Defining an optimal adherence threshold for patients taking subcutaneous anti-TNFs for inflammatory bowel diseases. Am J Gastroenterol. 2018;113:276–82.CrossRef
6.
go back to reference Greenley RN, Hommel KA, Nebel J, et al. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol. 2010;35:857–69.CrossRef Greenley RN, Hommel KA, Nebel J, et al. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol. 2010;35:857–69.CrossRef
7.
go back to reference Ruana J, Zhoua Y. Regaining normality: a grounded theory study of the illness experiences of Chinese patients living with Crohn’s disease. Int J Nurs Stud. 2019;93:87–96.CrossRef Ruana J, Zhoua Y. Regaining normality: a grounded theory study of the illness experiences of Chinese patients living with Crohn’s disease. Int J Nurs Stud. 2019;93:87–96.CrossRef
8.
9.
go back to reference Oris L, Rassart J, Prikken S, et al. Illness identity in adolescents and emerging adults with type 1 diabetes: introducing the Illness Identity Questionnaire. Diabetes Care. 2016;39:757–63.CrossRef Oris L, Rassart J, Prikken S, et al. Illness identity in adolescents and emerging adults with type 1 diabetes: introducing the Illness Identity Questionnaire. Diabetes Care. 2016;39:757–63.CrossRef
10.
go back to reference Oris L, Luyckx K, Rassart J, et al. Illness identity in adults with a chronic illness. J Clin Psychol Med Settings. 2018;25:429–40.CrossRef Oris L, Luyckx K, Rassart J, et al. Illness identity in adults with a chronic illness. J Clin Psychol Med Settings. 2018;25:429–40.CrossRef
11.
go back to reference Morea JM, Friend R, Bennett RM. Conceptualizing and measuring illness self-concept: a comparison with self-esteem and optimism in predicting fibromyalgia adjustment. Res Nurs Health. 2008;31:563–75.CrossRef Morea JM, Friend R, Bennett RM. Conceptualizing and measuring illness self-concept: a comparison with self-esteem and optimism in predicting fibromyalgia adjustment. Res Nurs Health. 2008;31:563–75.CrossRef
12.
go back to reference Guo L, Rohde J, Farraye FA. Stigma and disclosure in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:1010–6.CrossRef Guo L, Rohde J, Farraye FA. Stigma and disclosure in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:1010–6.CrossRef
13.
go back to reference Taft T, Keefer K, Leonhard C, Nealon-Woods M. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm Bowel Dis. 2009;15:1224–32.CrossRef Taft T, Keefer K, Leonhard C, Nealon-Woods M. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm Bowel Dis. 2009;15:1224–32.CrossRef
14.
go back to reference Sirois FM, Hirsch JK. A longitudinal study of the profiles of psychological thriving, resilience, and loss in people with inflammatory bowel disease. Br J Health Psychol. 2017;22:920–39.CrossRef Sirois FM, Hirsch JK. A longitudinal study of the profiles of psychological thriving, resilience, and loss in people with inflammatory bowel disease. Br J Health Psychol. 2017;22:920–39.CrossRef
15.
go back to reference Wynne B, McHugh L, Gao W. Acceptance and commitment therapy reduces psychological stress in patients with inflammatory bowel diseases. Gastroenterology. 2019;156:935–45.CrossRef Wynne B, McHugh L, Gao W. Acceptance and commitment therapy reduces psychological stress in patients with inflammatory bowel diseases. Gastroenterology. 2019;156:935–45.CrossRef
16.
go back to reference Tran V, Wiebe DJ, Fortenberry KT, Butler JM, Berg CA. Benefit finding, affective reactions to diabetes stress, and diabetes management among early adolescents. Health Psychol. 2011;30:212–9.CrossRef Tran V, Wiebe DJ, Fortenberry KT, Butler JM, Berg CA. Benefit finding, affective reactions to diabetes stress, and diabetes management among early adolescents. Health Psychol. 2011;30:212–9.CrossRef
17.
go back to reference Luyckx K, Oris L, Raymaekers K, et al. Illness identity in young adults with refractory epilepsy. Epilepsy Behav. 2018;80:48–55.CrossRef Luyckx K, Oris L, Raymaekers K, et al. Illness identity in young adults with refractory epilepsy. Epilepsy Behav. 2018;80:48–55.CrossRef
18.
go back to reference Knödler LL, Thomann PA, Ebert MP. The concept of illness identity in inflammatory bowel disease. J Crohns Colitis. 2020;S414-S415. Knödler LL, Thomann PA, Ebert MP. The concept of illness identity in inflammatory bowel disease. J Crohns Colitis. 2020;S414-S415.
19.
go back to reference Quintas R, Raggi A, Giovannetti AM, et al. Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010. Epilepsy Behav. 2012;25:60–7.CrossRef Quintas R, Raggi A, Giovannetti AM, et al. Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010. Epilepsy Behav. 2012;25:60–7.CrossRef
20.
go back to reference Arat S, Rassart J, Moons P, Luyckx K, Vandenberghe J, Westhovens R. Prospective associations between illness perceptions and health outcomes in patients with systemic sclerosis and systemic lupus erythematosus: a cross-lagged analysis. Rheumatol Adv Pract. 2018;2:rky007. Arat S, Rassart J, Moons P, Luyckx K, Vandenberghe J, Westhovens R. Prospective associations between illness perceptions and health outcomes in patients with systemic sclerosis and systemic lupus erythematosus: a cross-lagged analysis. Rheumatol Adv Pract. 2018;2:rky007.
21.
go back to reference Jackson JL, Gerardo GM, Daniels CJ, Vannatta K. Perceptions of disease-related stress: a key to better understanding patient-reported outcomes among survivors of congenital heart disease. J Cardiovasc Nurs. 2017;32:587–93.CrossRef Jackson JL, Gerardo GM, Daniels CJ, Vannatta K. Perceptions of disease-related stress: a key to better understanding patient-reported outcomes among survivors of congenital heart disease. J Cardiovasc Nurs. 2017;32:587–93.CrossRef
22.
go back to reference Rassart J, Oris L, Prikken S, et al. Illness identity and adjusting to type 1 diabetes: a four-wave longitudinal study. Health Psychol. 2021; in press. Rassart J, Oris L, Prikken S, et al. Illness identity and adjusting to type 1 diabetes: a four-wave longitudinal study. Health Psychol. 2021; in press.
23.
go back to reference Ho PYM, Hu W, Lee YY, et al. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res. 2019;17:107–18.CrossRef Ho PYM, Hu W, Lee YY, et al. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res. 2019;17:107–18.CrossRef
24.
go back to reference Kline RB. Principles and practice of structural equation modeling. New York, NY: Guilford Press; 2015. Kline RB. Principles and practice of structural equation modeling. New York, NY: Guilford Press; 2015.
25.
go back to reference Tommelein E, Mehuys E, Van Tongelen I, Brusselle G, Boussery K. Accuracy of the Medication Adherence Report Scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD. Ann Pharmacother. 2014;48:589–95.CrossRef Tommelein E, Mehuys E, Van Tongelen I, Brusselle G, Boussery K. Accuracy of the Medication Adherence Report Scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD. Ann Pharmacother. 2014;48:589–95.CrossRef
26.
go back to reference Selinger CP, Ochieng AO, George V, Leong RW. The accuracy of adherence self-report scales in patients on thiopurines for inflammatory bowel disease: a comparison with drug metabolite levels and medication possession ratios. Inflamm Bowel Dis. 2019;25:919–24.CrossRef Selinger CP, Ochieng AO, George V, Leong RW. The accuracy of adherence self-report scales in patients on thiopurines for inflammatory bowel disease: a comparison with drug metabolite levels and medication possession ratios. Inflamm Bowel Dis. 2019;25:919–24.CrossRef
27.
go back to reference Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiat Scand. 1983;67:361–70.CrossRef Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiat Scand. 1983;67:361–70.CrossRef
28.
go back to reference Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77.CrossRef Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77.CrossRef
29.
go back to reference Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985;49:71–5.CrossRef Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985;49:71–5.CrossRef
30.
go back to reference Pavot W, Diener E. Review of the Satisfaction With Life Scale. In: Diener E (Ed). Social indicators research series: Vol. 39. Assessing well-being: the collected works of Ed Diener. Springer Science + Business Media. 2009:101–17. Pavot W, Diener E. Review of the Satisfaction With Life Scale. In: Diener E (Ed). Social indicators research series: Vol. 39. Assessing well-being: the collected works of Ed Diener. Springer Science + Business Media. 2009:101–17.
31.
go back to reference EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef
32.
go back to reference Moons P, Van Deyk K, De Bleser L, et al. Quality of life and health status in adults with congenital heart disease: a direct comparison with healthy counterparts. Eur J Cardiovasc Prev Rehabil. 2006;13:407–13.CrossRef Moons P, Van Deyk K, De Bleser L, et al. Quality of life and health status in adults with congenital heart disease: a direct comparison with healthy counterparts. Eur J Cardiovasc Prev Rehabil. 2006;13:407–13.CrossRef
33.
go back to reference Irvine EJ, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol. 1996;91:1571–8. Irvine EJ, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol. 1996;91:1571–8.
34.
go back to reference Chen XL, Zhong LH, Wen Y, et al. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health Qual Life Outcomes. 2017;15:177.CrossRef Chen XL, Zhong LH, Wen Y, et al. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health Qual Life Outcomes. 2017;15:177.CrossRef
35.
go back to reference Benjamini Y, Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Method. 1995;57:289–300. Benjamini Y, Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Method. 1995;57:289–300.
36.
go back to reference Goshtasbi K, Abouzari M, Djalilian HR. Are acoustic neuroma association patients characteristically different than the general population patients? The benefits and drawbacks of survey-based studies. Otol Neurotol. 2019;40:979–80.CrossRef Goshtasbi K, Abouzari M, Djalilian HR. Are acoustic neuroma association patients characteristically different than the general population patients? The benefits and drawbacks of survey-based studies. Otol Neurotol. 2019;40:979–80.CrossRef
37.
go back to reference Sándor Z, Látos M, Pócza-Vége P, Havancsák R, Csabai M. The drawing version of the pictorial representation of illness and self-measure. Psychol Health. 2020;35:1033–48.CrossRef Sándor Z, Látos M, Pócza-Vége P, Havancsák R, Csabai M. The drawing version of the pictorial representation of illness and self-measure. Psychol Health. 2020;35:1033–48.CrossRef
38.
go back to reference Jordan C, Hayee B, Chalder T. Cognitive behaviour therapy for distress in people with inflammatory bowel disease: a benchmarking study. Clin Psychol Psychother. 2019;26:14.CrossRef Jordan C, Hayee B, Chalder T. Cognitive behaviour therapy for distress in people with inflammatory bowel disease: a benchmarking study. Clin Psychol Psychother. 2019;26:14.CrossRef
39.
go back to reference Leone D, Gilardi D, Corro BE, et al. Psychological characteristics of inflammatory bowel disease: a comparison between active and nonactive patients. Inflamm Bowel Dis. 2019;25:1399–407.CrossRef Leone D, Gilardi D, Corro BE, et al. Psychological characteristics of inflammatory bowel disease: a comparison between active and nonactive patients. Inflamm Bowel Dis. 2019;25:1399–407.CrossRef
Metadata
Title
Illness Identity in Inflammatory Bowel Disease
Authors
Jessica Rassart
Carine Van Wanseele
Lynn Debrun
Koen Matthijs
Philip Moons
Liesbet Van Bulck
Seher Arat
Lukas Van Oudenhove
Koen Luyckx
Publication date
07-03-2022
Publisher
Springer US
Published in
International Journal of Behavioral Medicine / Issue 1/2023
Print ISSN: 1070-5503
Electronic ISSN: 1532-7558
DOI
https://doi.org/10.1007/s12529-022-10072-y

Other articles of this Issue 1/2023

International Journal of Behavioral Medicine 1/2023 Go to the issue